You will be redirected to:

Continue
Logo - Kls
Logo - Kls
  • Playbook
  • Services
    Frame clinical development strategies
    Operationalize clinical development
    Implement RWE and Late Phase projects
    Enable life data science boosters
    Reach the next level in digital innovation
  • Insights
  • Technology
  • Careers
  • About us
    Company purpose
    Life science innovation
    Committed Keyrus
    Regulatory compliance
    Investors
    Management team
    Keyrus Group
    Locations

Accelerate the compliance process of your product portfolio in line with the new Medical Device Regulation (EU 2017/745)

23 months

Total duration of the mission

3 submissions

MDR conformity upgrades (DHF, CER, PMD, CDP, IFU, ...)

1 submission

new MDR CE marking - Class IIb device

Background

Following the enforcement of the new European medical device regulation (EU 2017/745 or 'MDR'), our client, a recognized player in the medical device industry with 100+ references marketed in France and internationally, had to ensure product compliance for its product portfolio, in order to be able to continue commercialize them.

Challenge

• High and punctual peak of activity • Shortage of regulatory and clinical experts capable of preparing submission applications. • Extended evaluation delays by Notified Bodies. • Risk of a sudden drop in revenue due to delays in obtaining MDR certificates.

Approach

Our client wanted to support the skill development of its internal teams, as well as get additional manpower to better absorb the peak activity. Keyrus Life Science sent one of its senior Clinical Project Manager consultants, trained to the MDR, to directly integrate within its teams, whose role was to: • Establish standardized compliance processes, • Provide clinical expertise in the construction of applications for the client's priority products, • Support the internal teams and the other more junior consultants

Key results

01
5 updated files of which 4 were submitted to the Notified Body (and validated)
02
Client satisfaction: mission renewed twice
03
Internal referent for the writing of IFU (Information For Users) notices to the MDR standard

Benefits

In addition to securing the CE marking of its strategic products, the clinical and regulatory expertise provided by the Keyrus consultant helped lay a solid foundation to facilitate the compliance of the rest of the client's product portfolio, and adapted to the client's strategy.

Share this key play

whatsapptwitter
linkedinfacebookworkplace

More key plays

Piloting through a pivotal study in cataract eye surgery helping patients recover their vision
Medical device approved for Hearing Loss
Accelerate the clinical validation of an anti-Covid treatment, thanks to an agile data management
Lower costs & risks associated with indication extensions, thanks to a robust meta-analysis of clinical data
Adapting service platforms (FSP) functionning to fit the client's new outsourcing strategy
Facilitate the provision of an innovative treatment thanks to a Managed Access Program (MAP)
Efficiently conducting a worldwide phase 2 clinical study with multiple partners
Achieving an end-to-end audit approval from Health Canada
Facilitate data mapping to SDTM by leveraging standardisation and A.I.
Speed up the development of clinical study documents
Logo - Kls
Headquarters

157 Rue Anatole France 92593 Levallois-Perret

Phone:+33 (0)1 41 34 10 00

LinkedInKlsInstagram
PlaybookServicesInsightsTechnologyCareersAbout us
Company purposeLife science innovationCommitted KeyrusRegulatory complianceInvestorsManagement teamKeyrus GroupLocations
Legal notice & Terms of use
Privacy policy
Data protection